These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16949936)

  • 21. The time frame of Epstein-Barr virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma.
    Lin SY; Chang KP; Hsieh MS; Ueng SH; Hao SP; Tseng CK; Pai PC; Chang FT; Tsai MH; Tsang NM
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1339-46. PubMed ID: 16169672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy.
    Ou DL; Chen CL; Lin SB; Hsu CH; Lin LI
    J Pathol; 2006 Nov; 210(3):363-73. PubMed ID: 16955398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
    Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM
    Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
    Ou XB; Chen XY; Wu MH; Luo WR
    Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
    Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Epstein-Barr virus-derived latent membrane protein-1 gene in various head and neck cancers: is it specific for nasopharyngeal carcinoma?
    Tsang NM; Chang KP; Lin SY; Hao SP; Tseng CK; Kuo TT; Tsai MH; Chung TC
    Laryngoscope; 2003 Jun; 113(6):1050-4. PubMed ID: 12782821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes.
    Tsai ST; Jin YT; Su IJ
    Cancer; 1996 Jan; 77(2):231-6. PubMed ID: 8625228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth.
    Huang YT; Liu MY; Tsai CH; Yeh TH
    Head Neck; 2010 Jul; 32(7):869-76. PubMed ID: 19827118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene.
    Hao SP; Tsang NM; Chang KP
    Laryngoscope; 2001 Apr; 111(4 Pt 1):650-2. PubMed ID: 11359135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
    Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
    Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
    Tanabe H; Yokota K; Kohgo Y
    J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syndecan-1 expression has prognostic significance in head and neck carcinoma.
    Anttonen A; Kajanti M; Heikkilä P; Jalkanen M; Joensuu H
    Br J Cancer; 1999 Feb; 79(3-4):558-64. PubMed ID: 10027330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.
    Horikawa T; Sheen TS; Takeshita H; Sato H; Furukawa M; Yoshizaki T
    Am J Pathol; 2001 Jul; 159(1):27-33. PubMed ID: 11438450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells.
    Li XP; Li G; Peng Y; Kung HF; Lin MC
    Biochem Biophys Res Commun; 2004 Feb; 315(1):212-8. PubMed ID: 15013447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.